1
Tell us about yourself
Complete a short enquiry form online or speak with our team.
We’ll learn a little about your health background and answer any questions you may have.
Thinking
about
joining a
research
trial?
Nightingale
Research Trials
Victoria
Access Nightingale’s clinical trials across Melbourne and Victoria with personalised support from our experienced cardiology and research teams.
Join our
Melbourne
Clinical Trials
Today
Now Recruiting
- Age > 18 years
- BMI ≥ 30kg/m2
- Heart function > 40% (tested within 12 months or at screening visit)
- Weekly self-injection
- Not taking Ozempic/Mounjaro for 90 days prior to screening
- Can be diabetic or non-diabetic
- Age > 18 years
- Lp(a) blood test taken at pre-screening or screening visit
- Oral tablet taken daily
- History of coronary artery disease (heart attack, bypass grafts or stroke) OR
- History of peripheral artery disease (amputation, stents in legs) OR
- At risk of having a coronary or peripheral arterial event (need to have 4 risk factors)
- Age > 18 years
- History of heart attack, stroke or vascular disease AND high blood pressure
- One additional risk factor for developing heart failure (assessed at screening)
- Diabetic or non-diabetic
- Oral tablet daily
- Age > 18 years
- Elevated heart failure bloods (tested at screening visit)
- Taking diuretic medication
- Oral tablet daily
Heart Failure with Obesity Study
Adelaide SA | Frankston VIC
A research study looking at a new medication for people with Heart Failure and Obesity.
Study visits: 24 Visits
Start dates: July 2026
Elevated Lp(a) in People at Risk of or with Established Heart Disease or Stroke
Adelaide SA | Frankston VIC
Effect of Muvalaplin tablet on the reduction of major adverse cardiovascular events in adults with elevated Lipoprotein(a), who have had a prior atherosclerotic cardiovascular event, or are at risk for a first atherosclerotic cardiovascular event.
Study visits:
Start dates: Jan 2026
Heart Disease, Diabetes and High Blood Pressure Study
Adelaide SA | Frankston VIC
A study to test a new medication in combination with Empagliflozin (a currently available medication) in people with Type 2 Diabetes, high blood pressure and cardiovascular disease.
Study visits:
Start dates: Sept 2025
Symptomatic Heart Failure Study
Frankston VIC
Effect of a new medication in combination with Empagliflozin (medication available currently) in patients with HF and EF>40%.
Study visits:
Start dates: June 2025
How it works
Joining a Clinical Trial is simple
2
Meet with our Research Team
If a study may be suitable, we’ll invite you to a complimentary screening appointment.
Together, we’ll determine whether the study is the right fit for you, while giving you the opportunity to learn more, ask questions and make an informed decision about participation.
3
Begin your study
Once enrolled, you’ll attend scheduled study visits with ongoing support from our experienced clinical team.
We’re here to answer questions, monitor your wellbeing and ensure you feel supported every step of the way.
Upcoming Trials
▼
There are currently no trials in this category.
Ongoing Trials
(Enrolment Closed)
▼
History of Heart Attack, Stroke or Kidney Disease with Overweight
Adelaide SA | Frankston VIC
Effect of a new medication on patients with established CVD and/or CKD.
- Age > 50 years
- BMI > 25 kg/m²
Completed Trials
▼
There are currently no trials in this category.